SCHEMBL2013244

SCHEMBL2013244

COC(=O)Oc1ccc2[nH]ccc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.61
MAOB P27338 3/20 0.49
HDAC1 Q13547 1/20 0.49
TUBB4A P04350 1/20 0.49
TUBB P07437 1/20 0.49
TUBA3C P0DPH7 1/20 0.49
TUBA1B P68363 1/20 0.49
TUBA4A P68366 1/20 0.49
TUBB4B P68371 1/20 0.49
TUBB3 Q13509 1/20 0.49
TUBB2A Q13885 1/20 0.49
TUBB8 Q3ZCM7 1/20 0.49
TUBA3E Q6PEY2 1/20 0.49
TUBA1A Q71U36 1/20 0.49
TUBA1C Q9BQE3 1/20 0.49
TUBB6 Q9BUF5 1/20 0.49
TUBB2B Q9BVA1 1/20 0.49
TUBB1 Q9H4B7 1/20 0.49
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4960212 0.87 MEN1 (0.62) MAOAHDAC1TAS1R3TAS1R1MEN1
SCHEMBL272553 0.83 MAOA (0.64) MAOAMAOBHDAC1TUBB4ATUBB
SCHEMBL4537980 0.83 MAOA (0.59) MAOAMAOBHDAC1TUBB4ATUBB
SCHEMBL1834224 0.81 MAOA (0.61) MAOAHDAC1TUBB4ATUBBTUBA3C
SCHEMBL17008380 0.81 MAOA (0.61) MAOAHDAC1TUBB4ATUBBTUBA3C
SCHEMBL27505830 0.81 MAOA (0.57) MAOAMAOBHDAC1TUBB4ATUBB
SCHEMBL2944091 0.80 KDM4E (0.47) MEN1KMT2APTGS2GAA
SCHEMBL8411386 0.80 MAOA (0.57) MAOAMAOBHDAC1TUBB4ATUBB
SCHEMBL8983204 0.80 MAOA (0.60) MAOAMAOBHDAC1TUBB4ATUBB
SCHEMBL29783647 0.80 MAOA (0.60) MAOAHDAC1TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011072779-A1 THIAZOLE DERIVATIVES FOR TREATING DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2011-06-23 WO claimed
EP-1943220-A2 NOVEL INDOLE-CONTAINING BETA AGONISTS, METHOD FOR PRODUCING THEM AND THEIR USE AS DRUGS Boehringer Ingelheim International GmbH (DE) 2008-07-16 EP disclosed
WO-2007048841-A2 NOVEL INDOLE-CONTAINING BETA AGONISTS, METHOD FOR PRODUCING THEM AND THEIR USE AS DRUGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-05-03 WO disclosed
EP-1597228-A2 SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS Sanofi-Aventis Deutschland GmbH (DE) 2005-11-23 EP disclosed
WO-2004072025-A2 SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-08-26 WO disclosed
EP-1165512-A2 METHOD FOR ARYLATING AZA-HETEROCYCLES WITH ACTIVATED AROMATIC COMPOUNDS IN THE PRESENCE OF CESIUM CARBONATE GÖDECKE GMBH (DE) 2002-01-02 EP disclosed
WO-2000059883-A2 METHOD FOR PRODUCING N-ARYL-AZA-HETEROCYCLES IN THE PRESENCE OF CESIUM CARBONATE Gödecke GmbH (DE) 2000-10-12 WO disclosed
EP-0197294-B1 BETA-LACTAM ANTIBIOTICS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS BAYER AG (DE) 1991-04-03 EP disclosed
EP-0197294-A2 Beta-lactam antibiotics, process for their preparation and their use as medicaments BAYER AG (DE) 1986-10-15 EP disclosed